Q4 EPS Forecast for Core Laboratories Boosted by Analyst

Core Laboratories Inc. (NYSE:CLB) – Equities research analysts at Zacks Research boosted their Q4 2026 earnings per share (EPS) estimates for shares of Core Laboratories in a research note issued to investors on Wednesday, November 12th. Zacks Research analyst Team now anticipates that the oil and gas company will post earnings of $0.26 per share for the quarter, up from their previous forecast of $0.24. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2027 earnings at $0.17 EPS.

Other analysts have also issued reports about the stock. Wall Street Zen raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, July 26th. Weiss Ratings upgraded Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Four research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $12.50.

Core Laboratories Price Performance

CLB traded up $0.30 on Friday, reaching $15.36. The company had a trading volume of 78,186 shares, compared to its average volume of 494,838. The company has a market capitalization of $715.35 million, a P/E ratio of 22.92, a PEG ratio of 8.30 and a beta of 1.40. The company has a current ratio of 2.37, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. The company has a fifty day moving average of $13.36 and a 200-day moving average of $12.18. Core Laboratories has a one year low of $9.72 and a one year high of $21.76.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, October 22nd. The oil and gas company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. Core Laboratories had a return on equity of 12.85% and a net margin of 6.21%.The company had revenue of $134.52 million for the quarter, compared to analyst estimates of $130.92 million. During the same period last year, the company earned $0.25 earnings per share. The company’s quarterly revenue was up .1% compared to the same quarter last year. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS.

Hedge Funds Weigh In On Core Laboratories

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Ridgewood Investments LLC lifted its holdings in shares of Core Laboratories by 2.7% in the first quarter. Ridgewood Investments LLC now owns 33,486 shares of the oil and gas company’s stock valued at $502,000 after purchasing an additional 874 shares in the last quarter. Platinum Investment Management Ltd. lifted its stake in Core Laboratories by 3.9% in the 3rd quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock worth $294,000 after acquiring an additional 889 shares in the last quarter. Illinois Municipal Retirement Fund boosted its position in Core Laboratories by 4.0% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 23,366 shares of the oil and gas company’s stock worth $289,000 after acquiring an additional 898 shares during the period. Advisors Capital Management LLC grew its stake in Core Laboratories by 0.3% during the 3rd quarter. Advisors Capital Management LLC now owns 275,975 shares of the oil and gas company’s stock valued at $3,411,000 after acquiring an additional 912 shares in the last quarter. Finally, Fox Run Management L.L.C. increased its holdings in shares of Core Laboratories by 5.9% in the 3rd quarter. Fox Run Management L.L.C. now owns 18,531 shares of the oil and gas company’s stock valued at $229,000 after purchasing an additional 1,038 shares during the period. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, November 24th. Stockholders of record on Monday, November 3rd will be issued a dividend of $0.01 per share. The ex-dividend date is Monday, November 3rd. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. Core Laboratories’s payout ratio is currently 5.97%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.